Stock QTTB Q32 BIO INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Q32 Bio Inc.

Equities

QTTB

US7469641051

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-10 pm EDT 		5-day change 1st Jan Change
20.69 USD +0.93% Intraday chart for Q32 Bio Inc. +19.39% +87.32%
Jul. 09 Q32 Bio Completes Enrollment in Mid-Stage Atopic Dermatitis Trial MT
Jul. 09 Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Neurogene Names Julie Jordan as Chief Medical Officer
MT
Homology Medicines, Inc. Approves Reduction in Workforce
CI
Homology Medicines, Inc. Announces Promotion of Julie Jordan to Chief Medical Officer
CI
Homology Medicines Promotes Chief Scientific Officer Albert Seymour to CEO
MT
Homology Medicines, Inc. Appoints Albert Seymour as Chief Executive Officer
CI
Homology Medicines, Inc. Announces Promotion of Albert Seymour to Member of the Board of Directors
CI
Homology Medicines, Inc. Announces Promotion of Albert Seymour to President
CI
Homology Medicines, Inc. Announces Resignation of Tim Kelly as Chief Operating Officer
CI
Homology Medicines, Inc. Appoints Beverly Davidson as Chair of Scientific Advisory Board
CI
Homology Medicines, Inc. Appoints Beverly Davidson, Ph.D., as Chair of Scientific Advisory Board
CI
Homology Medicines, Inc. Announces Promotion of Tim Kelly to Chief Operating Officer
CI
Insider Trends: Insider Sales Add to 90-Day Trend at Homology Medicines
MT
Insider Trends: Insider Adds to Selling Trend at Homology Medicines
MT
Insider Trends: Homology Medicines Insider Continues 90-Day Selling Trend
MT
Insider Trends: Insider Sales Continue 90-Day Trend at Homology Medicines
MT
Insider Trends: Selling By Insiders Lingers at Homology Medicines
MT
Insider Trends: Insider Adds to Selling Trend at Homology Medicines
MT
Homology Medicines Appoints Jeff Poulton to the Board of Directors
CI
Homology Medicines, Inc. Appoints Gabriel M. Cohn as Chief Medical Officer
CI
Homology Medicines, Inc. Announces Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. QTTB Stock
  4. News Q32 Bio Inc.
  5. Insiders